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In earlier communications (1, 2) there was described a rapid method 
for diagnosing meningococcal meningitis  and  ascertaining the  sero- 
logical type of the organism by means of precipitin tests carried out 
on the cerebrospinal fluid with monovalent antisera.  It was pointed 
out that a certain number of negative results occurred when the spinal 
fluid tested was drawn after the commencement of intrathecal serum 
therapy,  and,  furthermore, that  in  some instances  negative  results 
were due  apparently  to  the  fact  that  the  test  was  not  sufficiently 
sensitive to demonstrate the very small amounts of specific precipitin- 
ogen which  might  be  present  in  some  fluids.  At  that  time  only 
rabbit  monovalent  antimeningococcus sera were  available.  It  was 
thought that the percentage of negative results on fluids drawn before 
commencement of  therapy  might  be  reduced when  sera  of  higher 
precipitin titer became available. 
Since the publication of these papers  there has become available 
both  Type  I  and  Type  II  monovalent  antimeningococcus serum, 
prepared in horses, which has  a  precipitin  titer considerably higher 
than our best monovalent rabbit serum.  These sera have been used 
in the tests carried out on spinal fluids since that date.  Moreover, 
the technique of the precipitin test has also been modified so as to 
give more delicate readings. 
Material and Technique 
Spinal fluid was obtained from cases of known meningococcal  meningitis and 
from other cases of meningitic infection.  The precipitin test was carried out with 
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equal parts of undiluted  serum and spinal fluid  cleared by centrifugation.  The 
tubes were kept at 37°C. for 2 hours and the ring method was used for reading the 
results.  Only Type I-III and  Type II sera  were used.  Type IV serum was 
omitted since no strains of this type are being seen at this time and only an old 
stock strain was available for serum production (2); and Type III serum was not 
used since additional work has abundantly confirmed  the opinion, given elsewhere 
(3), that  there is no significant  difference between Types I  and III, so called,  as 
they occur today. 
0.1 cc. of each of the two monovalent sera is placed in a small tube of 4 mm. 
inner diameter and 5 cm. length.  0.1 cc. of the spinal fluid to be tested is carefully 
layered on top of each serum so that a clear line of junction is formed between the 
two fluids.  Any precipitate which forms can be seen as a distinct white ring at the 
point of junction, and, given the proper lighting conditions,  which are described 
below, can be seen with ease.  A reading is made immediately and the tubes are 
then placed in the 37°C.  water bath.  Further readings, without mixing of the 
fluids,  are made at the end of 1 and 2 hours.  In order to see slight amounts of 
precipitate it is essential to use suitable lighting conditions.  The best arrangement 
has been found to be the following.  A microscope lamp is used which  casts a 
strong bluish white beam of light.  This is placed slightly above and to the left 
of the line of horizontal vision and is so arranged that the beam of light is cast 
obliquely down and to the right across the line of vision.  The tubes are held in 
this oblique beam of light on a level with the eye and are examined against a dull 
black background.  Other means of lighting are as efficacious but the one herein 
described has proved satisfactory. 
RESULTS 
Following the introduction of the higher titer Type I-III and Type 
II horse sera and the modification of technique,  all spinal fluids from 
cases  of  meningitis  received  in  the  laboratory  have  been  tested  for 
their  precipiti  n  content  with  these  sera.  While  the  results  have 
shown a  high percentage of positive tests,  there  have been  a  certain 
number of negative reactions in fluids which would be expected to be 
positive  (Table  I).  Moreover  there  has  been  a  lack  of  agreement 
between the results obtained in our hands and in certain laboratories 
attached  to  the  hospitals  where  the  fluids  originated,  although  the 
same sera were available in all places and the technique  employed is 
believed to have been the same.  Since the lack of agreement always 
lay in our obtaining precipitin reactions on fluids which other labora- 
tories had found negative, it seemed probable that some change must 
be  occurring  during  the  time  between  the  two  tests  and  that  this 
change  might  be  lysis  of  the  organisms,  with  or  without  continued 
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Recently one of us has been in a  position to obtain fluids from a 
large outbreak of meningococcai meningitis due to Type I-III organ- 
isms.  ~  These fluids have been studied by the technique given above, 
using  the  antimeningococcal horse  sera.  The  results  on  70  spinal 
fluids from proven  cases of meningococcal meningitis show in brief 
that: 36 fluids reacted at once with Type I-III serum; 29 did not react 
at once; 4  reacted when first tested after 24 hours incubation; 1 re- 
acted when first tested after 48 hours at room temperature.  Of the 
29 fluids which did not react at once: 5 reacted after 24 hours incuba- 
tion;  13  reacted  after  48  hours  at  room  temperature  (not  tested 
earlier); 4 reacted after 48 hours but not after 24 hours at room tem- 
perature; 7 remained negative.  Of the 36 fluids reacting at once, 22 
TABLE  I 
No. of fluids positive in ho-  No. of fluids negative in both 
Type  mologous serum  sera 
I-III 
II 
II* 
VII 
Other forms of meningitis 
32 
10 
2 
1 
0 
3 
0 
1 
2 
14 
No heterologous precipitin reactions occurred.  The  positive reaction given 
in fluid from atypical Type II* or Type VII cases was in Type II serum and 
was very slight.  Such a reaction is to be expected (4). 
gave a  definite ring precipitate within 10 minutes of the two fluids 
coming into contact, thus allowing immediate diagnosis and typing to 
be made.  In the 14 other fluids the precipitate appeared by the end 
of 1 hour in the 37°C. water bath. 
It seems from this series that: 33.8 per cent of fluids can be typed at 
once; 21.5 per cent within 1 hour; 7.7 per cent within 1 day; 20.0 per 
cent between 1 hour and 2 days; 6.2 per cent within 2 days; and that 
10.8 per cent of fluids never give positive reactions.  This corresponds 
with the figures given in Table I where 3 out of 35 fluids from Type I 
meningococcal meningitis, or 8.6 per  cent failed to give positive re- 
actions. 
1  Our thanks are due to Dr. Huntingdon Williams  and the other members of the 
Baltimore City Department of Health whose hospitality and help made this work 
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It was further noted that in those cases in which the fluid gave an 
immediate reaction, the course of the disease was severe and the prog- 
nosis  grave, while in those cases in which the fluid failed to react or 
became positive only after  1 hour  to 2 days, 95 per cent recovered. 
This will form the subject of a further report (5). 
Specimens of concentrated  Type I  and  Type II  monovalent  sera 
have  been used  in  the  precipitin  test with  the  spinal  fluid in  some 
instances.  It  was  thought  that  such  sera  might  prove  even  more 
sensitive in the demonstration of minute amounts of specific precipi- 
tinogens.  The  results  are  given in  Table  II.  It  will  be seen  that 
TABLE  II 
Name or 
number 
C. 
C. 
W. 
50S 
5O6 
F. 
5O4 
498 
5OO 
501 
I 
0 
0 
0 
q: 
0 
4- 
+ 
4- 
4- 
0 
0 
Agglutination 
I-III 
I-III 
I-III 
I-III 
I-III 
H 
H 
II* 
II* 
VII 
Pneumo- 
coccus  lC 
Notes 
Before intrathecal serum 
After intrathecal serum 
After intrathecal serum 
II*  =  atypical Type II strain. 
the  homologous precipitin  reactions evoked are  stronger  than  those 
due  to  the  unconcentrated  sera.  However, this  advantage  is more 
than  offset by  the heterologous  reactions  which occur.  It  appears 
that the methods of concentration thus far adopted have resulted in a 
concentration not only of the specific antibodies in the serum but also 
of  the  non-specific  C  and P  antibodies.  This gives rise to cross re- 
actions between the two meningococcus types and even in one case to 
a reaction with a fluid from a case of pneumococcus meningitis.  This 
latter  result was to be expected on the basis of previous  work  (6). H.  E.  ALEXANDER AND  GEOFFREY RAKE  321 
SUMMARY 
Precipitin tests have been carried out on spinal fluid from cases of 
meningococcal and other forms of meningitis, with monovalent anti- 
meningococcus horse serum of high titer.  Using such a  test it has 
been possible within 2 hours to diagnose and type cases of Type I and 
Type  II  meningococcal meningitis.  In  a  certain  number of  cases 
fluids which were negative when first drawn became positive after 
standing for 1 or 2 days at 37°C. or room temperature.  In 9.5 per cent 
of all Type I  cases the fluids did not become positive.  Fluids from 
cases due to atypical meningococci may react with the type serum of 
the group to which they belong (i.e., Types II* and VII, which belong to 
group II, with Type II serum) but do not in every case.  Fluids from 
forms of meningitis other than meningococcal give no reaction.  The 
use of concentrated sera is not advantageous at present, owing to the 
heterologous reactions which occur. 
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